Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Meningococcal serogroup C-specific IgG antibody responses and serum bactericidal titres in children following vaccination with a meningococcal A/C polysaccharide vaccine.
Borrow R, Richmond P, Kaczmarski EB, Iverson A, Martin SL, Findlow J, Acuna M, Longworth E, O'Connor R, Paul J, Miller E. Borrow R, et al. Among authors: findlow j. FEMS Immunol Med Microbiol. 2000 May;28(1):79-85. doi: 10.1111/j.1574-695X.2000.tb01460.x. FEMS Immunol Med Microbiol. 2000. PMID: 10767611 Free article. Clinical Trial.
Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains.
Richmond P, Borrow R, Findlow J, Martin S, Thornton C, Cartwright K, Miller E. Richmond P, et al. Among authors: findlow j. Infect Immun. 2001 Apr;69(4):2378-82. doi: 10.1128/IAI.69.4.2378-2382.2001. Infect Immun. 2001. PMID: 11254596 Free PMC article.
Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection.
Burrage M, Robinson A, Borrow R, Andrews N, Southern J, Findlow J, Martin S, Thornton C, Goldblatt D, Corbel M, Sesardic D, Cartwight K, Richmond P, Miller E. Burrage M, et al. Among authors: findlow j. Infect Immun. 2002 Sep;70(9):4946-54. doi: 10.1128/IAI.70.9.4946-4954.2002. Infect Immun. 2002. PMID: 12183540 Free PMC article. Clinical Trial.
Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine.
Borrow R, Aaberge IS, Santos GF, Eudey TL, Oster P, Glennie A, Findlow J, Høiby EA, Rosenqvist E, Balmer P, Martin D. Borrow R, et al. Among authors: findlow j. Clin Diagn Lab Immunol. 2005 Aug;12(8):970-6. doi: 10.1128/CDLI.12.8.970-976.2005. Clin Diagn Lab Immunol. 2005. PMID: 16085915 Free PMC article.
Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac.
Findlow J, Taylor S, Aase A, Horton R, Heyderman R, Southern J, Andrews N, Barchha R, Harrison E, Lowe A, Boxer E, Heaton C, Balmer P, Kaczmarski E, Oster P, Gorringe A, Borrow R, Miller E. Findlow J, et al. Infect Immun. 2006 Aug;74(8):4557-65. doi: 10.1128/IAI.00466-06. Infect Immun. 2006. PMID: 16861642 Free PMC article. Clinical Trial.
96 results